文献速递产科母胎医学

先天性肌张力低下:产前检测的系统性方法

Congenital hypotonia: systematic approach for prenatal detection.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

这项回顾性观察研究纳入了2012至2020年间单中心26例先天性肌张力低下病例,其中10例(38.5%)产前诊断。针对性超声扫描使产前检出率从0%提高至62.5%(P=0.003),全外显子组测序在87.5%的受检病例中检出致病突变。理论上针对单个或两个非特异性超声征象进行针对性扫描并全面基因评估的模型,检出率分别为88.5%和57.7%。

要点

  • 先天性肌张力低下产前检出率低,本队列总体产前检出率为38.5%。
  • 针对性超声扫描可显著提高产前检出率(62.5% vs 0%,P=0.003)。
  • 全面基因检测尤其是全外显子组测序是诊断基石。

核心结论

  • 先天性肌张力低下罕见且产前检出率低,超声征象自晚孕期中期开始可见。
  • 针对性扫描显著提高产前检出率,全面基因检测尤其是全外显子组测序是诊断基石。
  • 提供了可能提高产前检出率的理论诊断模型。

研究设计与样本

  • 回顾性观察研究,纳入2012至2020年间单中心单胎妊娠,病例组为26例先天性肌张力低下,对照组为95 105例单胎活产。

主要发现

  • 病例组26例中10例(38.5%)产前诊断,先天性肌张力低下患病率为1:3658。
  • 颈项透明层厚度在22例受检者中均正常,13-17周早期畸形扫描在23例受检者中均正常,19-25周中期扫描在24例中4例(16.7%)异常。
  • 针对性扫描在16例受检者中产前检出率为62.5%,未行针对性扫描的妊娠为0%(P=0.003)。
  • 基因诊断异常21例(80.8%):染色体微阵列分析2例(9.5%)、全外显子组测序14例(66.7%)、甲基化分析5例(23.8%);染色体微阵列分析异常率8%(2/25),全外显子组测序致病突变检出率87.5%(14/16)。
  • 病例组与当地单胎活产人群比较:羊水过多64.0% vs 3.0%(P<0.0001)、持续性臀位58.3% vs 4.2%(P<0.0001)、宫内生长受限30.8% vs 3.0%(P<0.0001)、孕妇感知胎动减少32.0% vs 4.7%(P<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Congenital hypotonic conditions are rare and heterogeneous, and some are severely debilitating or lethal. Contrary to its prominent postnatal manifestation, the prenatal presentation of hypotonia is frequently subtle, inhibiting prenatal detection. We aimed to characterize the prenatal sonographic manifestation of congenital hypotonia throughout pregnancy, evaluate the yield of diagnostic tests and propose diagnostic models to increase its prenatal detection. METHODS: This was a retrospective observational study of singleton pregnancies with congenital hypotonia, diagnosed either prenatally or immediately after birth, at a single tertiary center between the years 2012 and 2020. Prenatally, hypotonia was diagnosed if a fetus showed sonographic or clinical signs suggestive of hypotonia and had a confirmed underlying genetic condition, or in the absence of a known genetic abnormality if the fetus exhibited multiple prominent signs suggestive of hypotonia. Postnatally, it was diagnosed in neonates displaying reduced muscle tone leading to reduced spontaneous movement, reduced swallowing or feeding difficulty. We reviewed the medical records of pregnant patients carrying fetuses subsequently diagnosed with congenital hypotonia and assessed the yield of ultrasound scans, fetal magnetic resonance imaging, computed tomography and genetic tests. The detection rate of sonographic signs suggesting fetal hypotonia was calculated. The prevalence of non-specific signs, including polyhydramnios, persistent breech presentation, intrauterine growth restriction and maternal perception of reduced fetal movement, were compared between the study group and the local liveborn singleton population. Potential detection rates of different theoretical semiotic diagnostic models, differing in the threshold for referral for a targeted scan, were assessed based on the cohort's data. RESULTS: The study group comprised 26 cases of congenital hypotonia, of which 10 (38.5%) were diagnosed prenatally, and the controls included 95 105 singleton live births, giving a prevalence of congenital hypotonia of 1:3658. Nuchal translucency thickness and the early anomaly scan at 13-17 weeks were normal in all 22 and 23 cases, respectively, in which this was performed. The mid-trimester scan performed at 19-25 weeks was abnormal in four of 24 (16.7%) cases. The overall prenatal detection rate of congenital hypotonic conditions in our cohort was 38.5%. Only cases which underwent a targeted scan were detected and, among the 16 cases which underwent this scan, the prenatal detection rate was 62.5% compared with 0% in pregnancies that did not undergo this scan (P = 0.003). An abnormal genetic diagnosis was obtained in 21 (80.8%) cases using the following modalities: chromosomal microarray analysis (CMA) in two (9.5%), whole-exome sequencing (WES) in 14 (66.7%) and methylation analysis in five (23.8%). CMA was abnormal in 8% (2/25) of the cases and WES detected a causative genetic mutation in 87.5% (14/16) of the cases in which these were performed. Comparison of non-specific signs in the study group with those in the local singleton population showed that hypotonic fetuses had significantly more polyhydramnios (64.0% vs 3.0%, P < 0.0001), persistent breech presentation (58.3% vs 4.2%, P < 0.0001), intrauterine growth restriction (30.8% vs 3.0%, P < 0.0001) and maternal perception of reduced fetal movement (32.0% vs 4.7%, P < 0.0001). Prenatally, the most commonly detected signs supporting a diagnosis of hypotonia were structural anomaly (62.5%, 10/16), reduced fetal movement (46.7%, 7/15), joint contractures (46.7%, 7/15) and undescended testes ≥ 30 weeks (42.9%, 3/7 males). Proposed diagnostic strategies that involved performing a targeted scan for a single non-specific ultrasound sign or two such signs, and then carrying out a comprehensive genetic evaluation for any additional sign, offered theoretical detection rates in our cohort of 88.5% and 57.7%, respectively. CONCLUSIONS: Congenital hypotonic conditions are rare and infrequently detected prenatally. Sonographic signs are visible from the late second trimester. A targeted scan increases prenatal detection significantly. Comprehensive genetic testing, especially WES, is the cornerstone of diagnosis in congenital hypotonia. Theoretical diagnostic models which may increase prenatal detection are provided. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Weissbach T, Hausman-Kedem M, Yanay Z, et al. Congenital hypotonia: systematic approach for prenatal detection. Ultrasound Obstet Gynecol. 2023. PMID: 36779229. doi:10.1002/uog.26178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。